Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 368101 - 368120 out of 498614 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Romania (legislatie) | (L01FD01) trastuzumab | OGIVRI 150 mg | Cutie x 1 flac. cu capacitatea de 15 ml din sticla transparenta de tip I cu dop din cauciuc butilic laminat cu film de fluoro-rezina continând trastuzumab 150 mg,PULB. PT.CONC. PT. SOL. PERF., 150 mg | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | VIATRISLIMITED-IRLANDA |
Romania (legislatie) | (L01FD01) trastuzumab | OGIVRI 150 mg | Cutie x 1 flac. cu capacitatea de 15 ml din sticla transparenta de tip I cu dop din cauciuc butilic laminat cu film de fluoro-rezina continând trastuzumab 150 mg (4 ani),PULB. PT.CONC. PT. SOL. PERF., 150 mg | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BIOSIMILARCOLLABORATIONSIRELANDLIMITED-IRLANDA |
Romania (legislatie) | (L01FD01) trastuzumab | TRAZIMERA 150 mg | Cutie cu 1 flac. cu capacitatea de 15 ml continanad 150 mg trastuzumab,PULB. PT. CONC. PT. SOL. PERF., 150mg | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PFIZEREUROPEMAEEIG |
Romania (legislatie) | (L01FD01) trastuzumab | ZERCEPAC 150 mg | Cutie cu 1 flac. cu capacitatea de 20 ml din sticla cu dop din cauciuc bromobutilic x 150 mg pulb. pt. conc. pt. sol. perf.,PULB. PT. CONC. PT.SOL. PERF., 150mg | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | ACCORDHEALTHCARES.L.U. |
Romania (legislatie) | (L01FD01) trastuzumab | KANJINTI 420 mg | Cutie cu 1 flac. cu capacitatea de 50 ml din sticla transparenta ce conține 420 mg trastuzumab,PULB. PT. CONC. PT. SOL. PERF., 420mg | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AMGENEUROPEB.V. |
Romania (legislatie) | (L01FD01) trastuzumab | TRAZIMERA420 mg | Cutie cu 1 flac. cu capacitatea de 30 ml continanad 420 mg trastuzumab,PULB. PT. CONC. PT. SOL. PERF., 420mg | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PFIZEREUROPEMAEEIG |
Romania (legislatie) | (L01FD01) trastuzumab | ZERCEPAC 420 mg | Cutie cu 1 flac. cu capacitatea de 50 ml din sticla cu dop din cauciuc bromobutilic x 420 mg pulb. pt. conc. pt. sol. perf.,PULB. PT. CONC. PT.SOL. PERF., 420mg | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | ACCORDHEALTHCARES.L.U. |
Romania (legislatie) | (L01FD01) trastuzumab | ZERCEPAC 60mg | Cutie cu 1 flac. cu capacitatea de 10 ml din sticla cu dop din cauciuc bromobutilic x 60 mg pulb. pt. conc. pt. sol. perf.,PULB. PT. CONC. PT. SOL. PERF., 60mg | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | ACCORDHEALTHCARES.L.U. |
Romania (legislatie) | (L01FD02) pertuzumab | PERJETA 420 mg | Cutie x 1 flacon din sticla x 14ml concentrat pentru soluție perfuzabila x420 mg pertuzumab,CONC. PT. SOL. PERF., 420 mg | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHEREGISTRATIONGMBH |
Romania (legislatie) | (L01FD03) trastuzumab emtansine | KADCYLA 100 mg | Cutie cu un flacon a 15ml x100 mg concentrat pentru soluție perfuzabila,PULB. PT. CONC. PT. SOL. PERF., 100mg | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHEREGISTRATIONGMBH |
Romania (legislatie) | (L01FD03) trastuzumab emtansine | KADCYLA 160 mg | Cutie cu un flacon a 20ml x160 mg concentrat pentru soluție perfuzabila,PULB. PT. CONC. PT. SOL. PERF., 160mg | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHEREGISTRATIONGMBH |
Romania (legislatie) | (L01FD04) trastuzumab deruxtecan | ENHERTU 100 mg | Cutie cu 1 flac. din sticla bruna de 10 ml care conține 100 mg trastuzumab deruxtecan (3 ani),PULB. PT. CONC. PT. SOL. PERF., 100 mg | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | DAIICHISANKYOEUROPEGMBH-GERMANIA |
Romania (legislatie) | (L01FE01) cetuximab | ERBITUX 5mg/ml | Cutie x 1 flac. din sticla x 20 ml sol. perf.,SOL. PERF., 5mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Colorectal Neoplasms | MERCKEUROPEB.V. |
Romania (legislatie) | (L01FE02) panitumumab | VECTIBIX 20mg/ml | Cutie x1 flac. x400mg panitumumab x 20ml,CONC.PT. SOL. PERF., 20mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AMGENEUROPEB.V. |
Romania (legislatie) | (L01FE02) panitumumab | VECTIBIX 20mg/ml | Cutie x 1 flac. x 100mg panitumumab x 5ml,CONC.PT. SOL. PERF., 20mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AMGENEUROPEB.V. |
Romania (legislatie) | (L01FF01) nivolumab | OPDIVO 10 mg/ml | Cutie cu 1flac. din sticla de tip Ix40 mg conc. pt. sol. perf. (2 ani),CONC.PT. SOL. PERF., 10 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | BRISTOL-MYERSSQUIBBPHARMAEEIG-IRLANDA |
Romania (legislatie) | (L01FF01) nivolumab | OPDIVO 10 mg/ml | Cutie cu 1flac.dinsticlade tip I x10ml (100 mg conc. pt. sol. perf.) (3 ani-flacon nedeschis),CONC.PT. SOL. PERF., 10 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | BRISTOL-MYERSSQUIBBPHARMAEEIG-IRLANDA |
Romania (legislatie) | (L01FF01) nivolumab | OPDIVO 10 mg/ml | Cutie cu 1flac.dinsticlade tip I x12 ml (120 mg conc. pt. sol. perf.) (2 ani),CONC.PT. SOL. PERF., 10 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | BRISTOL-MYERSSQUIBBPHARMAEEIG-IRLANDA |
Romania (legislatie) | (L01FF02) pembrolizumab | KEYTRUDA 25 mg/ml | Cutie cu 1 flac. din sticla transparenta x4ml concentrat ( 100 mg pembrolizumab) ( 2 ani),CONC. PT. SOL. PERF., 25 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MERCKSHARPDOHMEB.V.-OLANDA |
Romania (legislatie) | (L01FF03) durvalumab | IMFINZI 50 mg/ml | Cutie cu 1 flac. din sticla a 2,4 ml conc. (care conține 120 mg durvalumab) (3 ani),CONC. PT. SOL. PERF., 50mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAAB-SUEDIA |